Labeled molecular imaging agents and methods of use

US9468693B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9468693-B2
Application numberUS-201414161863-A
CountryUS
Kind codeB2
Filing dateJan 23, 2014
Priority dateJan 23, 2014
Publication dateOct 18, 2016
Grant dateOct 18, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Imaging agents are described that comprise labeled substrates capable of being introduced into cells via the cystine/glutamate antiporter. The substrates may be used for imaging or detecting oxidative stress in cells by introducing the labeled agents into cells via the cystine/glutamate antiporter and subsequent detection.

First claim

Opening claim text (preview).

The invention claimed is: 1. An imaging agent comprising a compound of Formula I wherein X is 18 F, 3 H, —(CH 2 ) m Z, —CH 2 —O—(CH 2 ) m Z, or —O—(CH 2 ) m Z; Z is 18 F or 3 H; m is an integer between 1 and 5; Y is O—CH 2 , CH 2 —O, CH 2 —CH 2 , CH 2 —CH 2 —CH 2 , O—CH 2 —CH 2 , or CH 2 —O—CH 2 ; and Ar is a 3-substituted phenyl, 4-substituted phenyl, 4-substituted naphthalene-1-yl, 5-substituted naphthalene-1-yl, or 6-substituted naphthalene-2-yl. 2. The agent of claim 1 wherein X is —O—(CH 2 ) m Z. 3. The agent of claim 2 wherein Z is 18 F or 3 H. 4. The agent of claim 3 wherein Z is a singularly occurring 18 F. 5. The agent of claim 1 wherein Formula I is 6. The agent of claim 1 wherein Formula I is 7. The agent of claim 1 wherein Formula I is

Assignees

Inventors

Classifications

  • Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions · CPC title

  • for testing the pathological state of an organism · CPC title

  • having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil · CPC title

  • Heterocyclic compounds · CPC title

  • Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9468693B2 cover?
Imaging agents are described that comprise labeled substrates capable of being introduced into cells via the cystine/glutamate antiporter. The substrates may be used for imaging or detecting oxidative stress in cells by introducing the labeled agents into cells via the cystine/glutamate antiporter and subsequent detection.
Who is the assignee on this patent?
Gen Electric
What technology area does this patent fall under?
Primary CPC classification A61K49/0004. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).